Researchers have developed an innovative, low-cost wound dressing that harnesses water-activated electrical stimulation to significantly accelerate healing in diabetic mice, potentially offering a game-changing solution for chronic wound treatment.
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced the completion of its £10.9m (about US$13.3m) Series B investment round.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
© Rajaram Kaveti